NASDAQ · TBBK

The Bancorp Inc.

$67.40 +$0.42 (+0.63%) 1D After hours

Key Metrics

$2.79B
Market cap
12.07×
P/E · TTM
Revenue · TTM
$231.11M
Net income
EPS · TTM $4.82
Dividend yield
Free cash flow $210.96M
Beta · 1Y 1.17
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 27
    From its Jan 29 high, the share price fell 27%.

    Peak close $70.53 on Jan 29; trough close $51.48 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -27%
  • Feb 27
    The stock moved -8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27
  • Jan 30
    The stock moved -15.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jan 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.79B
Enterprise value
Shares outstanding41.6M
52-wk range$50.20 – $81.65
Avg volume · 20D484.8K
Net cash
Book value / share$14.53
IndustryNational Commercial Banks
ExchangeNASDAQ
About The Bancorp Inc.
IPO dateFeb 3, 2004
Employees733

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E12.07
P/S
P/FCF13.22
EV/EBITDA
EV/Sales
Graham №$39.69

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 31.1% · 36.7%

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF $217.75M
Capex −$6.79M
Free cash flow $210.96M
Buybacks $390.97M
Dividends paid
Shareholder yield 14.0%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$39.69 vs $67.40
Trades 1.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings